Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-06-24 Sale | 2022-06-28 4:01 pm | Jasper Therapeutics Inc. | JSPR | Lis William Director | 49,486 | $2.0498 | $101,434 | 40,486 (Direct) | View |
| 2021-04-21 Sale | 2021-04-23 5:15 pm | Amplitude Healthcare Acquisition Corp | AMHC | GLAZER CAPITAL LLC GLAZER PAUL J 10% Owner | 152,883 | $9.92 | $1,516,599 | 895,059 (Indirect) | View |
| 2021-04-19 Sale | 2021-04-21 08:09 am | Amplitude Healthcare Acquisition Corp | AMHC | GLAZER CAPITAL LLC GLAZER PAUL J 10% Owner | 2,060 | $9.97 | $20,538 | 1,047,942 (Indirect) | View |
| 2021-02-18 Sale | 2021-02-22 6:13 pm | Amplitude Healthcare Acquisition Corp | AMHC | GLAZER CAPITAL LLC GLAZER PAUL J 10% Owner | 12,810 | $10.46 | $134,005 | 1,050,002 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-10-12 Option Award | 2022-10-13 8:08 pm | N/A N/A | Jasper Therapeutics Inc. | JSPR | MARTELL RON CEO | 506,250 | $0 | 506,250 (Direct) | View |
| 2022-10-12 Option Award | 2022-10-13 8:07 pm | N/A N/A | Jasper Therapeutics Inc. | JSPR | Klein Lawrence Otto Director | 24,500 | $0 | 24,500 (Direct) | View |
| 2022-10-12 Option Award | 2022-10-13 8:05 pm | N/A N/A | Jasper Therapeutics Inc. | JSPR | EMSTER KURT VON Director | 30,250 | $0 | 30,250 (Direct) | View |
| 2022-10-12 Option Award | 2022-10-13 8:03 pm | N/A N/A | Jasper Therapeutics Inc. | JSPR | Shizuru Judith Anne Director | 29,500 | $0 | 1,159,012 (Direct) | View |
| 2022-10-12 Option Award | 2022-10-13 8:02 pm | N/A N/A | Jasper Therapeutics Inc. | JSPR | Mahal Jeetinder Singh See Remarks | 214,722 | $0 | 324,349 (Direct) | View |
| 2022-10-12 Option Award | 2022-10-13 8:00 pm | N/A N/A | Jasper Therapeutics Inc. | JSPR | Nolet Chris Director | 32,500 | $0 | 32,500 (Direct) | View |
| 2022-10-12 Option Award | 2022-10-13 7:58 pm | N/A N/A | Jasper Therapeutics Inc. | JSPR | Lis William Director | 29,500 | $0 | 69,986 (Direct) | View |
| 2022-10-12 Option Award | 2022-10-13 7:56 pm | N/A N/A | Jasper Therapeutics Inc. | JSPR | French Anna Louise Director | 30,750 | $0 | 30,750 (Direct) | View |
| 2022-08-01 Ownership | 2022-08-11 4:57 pm | N/A N/A | Jasper Therapeutics Inc. | JSPR | Carlyle Group Inc. Carlyle Holdings I GP Inc. Carlyle Holdings I GP Sub L.L.C. Carlyle Holdings I L.P. CG Subsidiary Holdings L.L.C. TC Group LLC Carlyle Investment Management LLC Carlyle Genesis UK LLC 10% Owner | 0 | $0 | 5,706,603 (Indirect) | View |
| 2022-04-07 Option Award | 2022-04-08 4:01 pm | N/A 2032-04-07 | Jasper Therapeutics Inc. | JSPR | Mahal Jeetinder Singh See Remarks | 48,441 | $0 | 48,441 (Direct) | View |
| 2022-03-21 Option Award | 2022-03-23 6:06 pm | N/A 2032-03-21 | Jasper Therapeutics Inc. | JSPR | MARTELL RON CEO | 1,704,328 | $0 | 1,704,328 (Direct) | View |
| 2022-03-21 Option Award | 2022-03-23 6:05 pm | N/A 2032-03-21 | Jasper Therapeutics Inc. | JSPR | Klein Lawrence Otto Director | 78,045 | $0 | 78,045 (Direct) | View |
| 2022-03-21 Option Award | 2022-03-23 6:04 pm | N/A 2032-03-21 | Jasper Therapeutics Inc. | JSPR | EMSTER KURT VON Director 10% Owner | 78,045 | $0 | 78,045 (Direct) | View |
| 2022-03-21 Option Award | 2022-03-23 6:04 pm | N/A 2032-03-21 | Jasper Therapeutics Inc. | JSPR | Heller Kevin N. See Remarks | 7,500 | $0 | 7,500 (Direct) | View |
| 2022-03-21 Option Award | 2022-03-23 6:03 pm | N/A 2032-03-21 | Jasper Therapeutics Inc. | JSPR | Shizuru Judith Anne Director | 78,045 | $0 | 78,045 (Direct) | View |
| 2022-03-21 Option Award | 2022-03-23 6:02 pm | N/A 2032-03-21 | Jasper Therapeutics Inc. | JSPR | Mahal Jeetinder Singh CFO COO | 94,772 | $0 | 94,772 (Direct) | View |
| 2022-03-21 Option Award | 2022-03-23 6:01 pm | N/A 2032-03-21 | Jasper Therapeutics Inc. | JSPR | Nolet Chris Director | 78,045 | $0 | 78,045 (Direct) | View |
| 2022-03-21 Option Award | 2022-03-23 6:01 pm | N/A 2032-03-21 | Jasper Therapeutics Inc. | JSPR | Lis William See Remarks | 197,472 | $0 | 287,444 (Direct) | View |
| 2022-03-21 Option Award | 2022-03-23 6:00 pm | N/A 2032-03-21 | Jasper Therapeutics Inc. | JSPR | French Anna Louise Director | 78,045 | $0 | 78,045 (Direct) | View |
| 2022-03-21 Option Award | 2022-03-23 5:30 pm | N/A 2032-03-21 | Jasper Therapeutics Inc. | JSPR | Abingworth LLP 10% Owner | 78,045 | $0 | 78,045 (Indirect) | View |
| 2021-09-24 Ownership | 2021-10-04 09:10 am | N/A N/A | Jasper Therapeutics Inc. | JSPR | ROCHE HOLDING LTD ROCHE FINANCE LTD 10% Owner | 0 | $0 | 4,624,606 (Direct) | View |
| 2021-09-24 Ownership | 2021-10-01 4:30 pm | N/A N/A | Jasper Therapeutics Inc. | JSPR | Abingworth LLP 10% Owner | 0 | $0 | 5,628,558 (Indirect) | View |
| 2021-09-24 Ownership | 2021-10-01 4:12 pm | N/A N/A | Jasper Therapeutics Inc. | JSPR | EMSTER KURT VON Director 10% Owner | 0 | $0 | 5,628,558 (Indirect) | View |
| 2021-09-24 Ownership | 2021-10-01 4:10 pm | N/A 2030-09-01 | Jasper Therapeutics Inc. | JSPR | Heller Kevin N. VP | 0 | $0 | 657,769 (Direct) | View |
| 2021-09-24 Ownership | 2021-10-01 4:10 pm | N/A N/A | Jasper Therapeutics Inc. | JSPR | Shizuru Judith Anne Director | 0 | $0 | 1,275,682 (Direct) | View |
| 2021-09-24 Ownership | 2021-10-01 4:09 pm | N/A N/A | Jasper Therapeutics Inc. | JSPR | Mahal Jeetinder Singh See remarks | 0 | $0 | 292,340 (Direct) | View |
| 2021-09-24 Ownership | 2021-10-01 4:08 pm | N/A 2030-05-31 | Jasper Therapeutics Inc. | JSPR | Lis William CEO | 0 | $0 | 959,945 (Direct) | View |
| 2021-09-24 Ownership | 2021-10-01 4:08 pm | N/A N/A | Jasper Therapeutics Inc. | JSPR | Qiming U.S. Healthcare Fund II L.P. Qiming U.S. Healthcare GP II LLC MCDADE MARK 10% Owner | 0 | $0 | 5,852,982 (Direct) | View |
| 2021-09-24 Disposition | 2021-09-28 4:33 pm | N/A N/A | Amplitude Healthcare Acquisition Corp | JSPR | Clifford Kenneth F FORMER OFFICER | 200,000 | $0 | 2,300,000 (Indirect) | View |
| 2021-09-24 Exercise | 2021-09-28 4:33 pm | N/A N/A | Amplitude Healthcare Acquisition Corp | JSPR | Clifford Kenneth F FORMER OFFICER | 2,300,000 | $0 | 2,300,000 (Indirect) | View |
| 2021-09-24 Disposition | 2021-09-28 4:32 pm | N/A N/A | Amplitude Healthcare Acquisition Corp | JSPR | HOFFEN HOWARD I FORMER DIRECTOR | 200,000 | $0 | 2,300,000 (Indirect) | View |
| 2021-09-24 Exercise | 2021-09-28 4:32 pm | N/A N/A | Amplitude Healthcare Acquisition Corp | JSPR | HOFFEN HOWARD I FORMER DIRECTOR | 2,300,000 | $0 | 2,300,000 (Indirect) | View |
| 2021-09-24 Disposition | 2021-09-28 4:32 pm | N/A N/A | Amplitude Healthcare Acquisition Corp | JSPR | VENKATARAMAN BALAJI FORMER DIRECTOR AND OFFICER | 200,000 | $0 | 2,300,000 (Indirect) | View |
| 2021-09-24 Exercise | 2021-09-28 4:32 pm | N/A N/A | Amplitude Healthcare Acquisition Corp | JSPR | VENKATARAMAN BALAJI FORMER DIRECTOR AND OFFICER | 2,300,000 | $0 | 2,300,000 (Indirect) | View |
| 2021-09-24 Disposition | 2021-09-28 4:29 pm | N/A N/A | Amplitude Healthcare Acquisition Corp | JSPR | Amplitude Healthcare Holdings LLC 10% Owner | 200,000 | $0 | 2,300,000 (Direct) | View |
| 2021-09-24 Exercise | 2021-09-28 4:29 pm | N/A N/A | Amplitude Healthcare Acquisition Corp | JSPR | Amplitude Healthcare Holdings LLC 10% Owner | 2,300,000 | $0 | 2,300,000 (Direct) | View |